These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 2856785
21. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension. Bénétos A, Laflèche A, Asmar R, Gautier S, Safar A, Safar ME. J Hum Hypertens; 1996 Feb; 10(2):77-82. PubMed ID: 8867559 [Abstract] [Full Text] [Related]
23. Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension. Saruta T, Ogihara T, Matsuoka H, Suzuki H, Toki M, Hirayama Y, Nonaka K, Takahashi K. Hypertens Res; 2007 Aug; 30(8):729-39. PubMed ID: 17917321 [Abstract] [Full Text] [Related]
24. Losartan with hydrochlorothiazide in the treatment of hypertension. Schoenberger JA, Losartan Research Group. J Hypertens Suppl; 1995 Jul; 13(1):S43-7. PubMed ID: 18800455 [Abstract] [Full Text] [Related]
25. Low-dose captopril alone and in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension. Pandhi P, Mondal S, Sharma BK, Sharma PL, Wahi PL. Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):294-7. PubMed ID: 3525427 [Abstract] [Full Text] [Related]
26. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects. Costa FV, Borghi C, Ambrosioni E. Clin Ther; 1984 Jun; 6(5):708-18. PubMed ID: 6383615 [Abstract] [Full Text] [Related]
27. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C, Sánchez G, Boyer JL, Delmar M, Serrano PA. Arch Inst Cardiol Mex; 1982 Jun; 52(4):295-300. PubMed ID: 6291470 [Abstract] [Full Text] [Related]
28. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
29. [Effect of captopril in essential hypertension (author's transl)]. Mimran A, Targhetta R, Laroche B. Nouv Presse Med; 1981 Apr 30; 10(19):1579-82. PubMed ID: 7025849 [Abstract] [Full Text] [Related]
30. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension. Zweifler AJ, Julius S, Nicholls MG. Arch Intern Med; 1981 Jun 30; 141(7):907-10. PubMed ID: 6263204 [Abstract] [Full Text] [Related]
31. [Evaluation of the antihypertensive efficacy of lisinopril and captopril associated with hydrochlorothiazide by ambulatory measurement of arterial pressure]. Vaïsse B, Renucci JF, Delage Y, Madonna O, Gressin V, Poggi L. Ann Cardiol Angeiol (Paris); 1993 Dec 30; 42(10):566-72. PubMed ID: 8117053 [Abstract] [Full Text] [Related]
32. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives]. Weisser B, Vetter H, Mengden T. Dtsch Med Wochenschr; 2003 Mar 14; 128(11):541-4. PubMed ID: 12635025 [Abstract] [Full Text] [Related]
33. Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration. Lindroos M, Lehtonen A. Int J Clin Pharmacol Ther Toxicol; 1984 Dec 14; 22(12):643-5. PubMed ID: 6396239 [Abstract] [Full Text] [Related]
34. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination. Papademetriou V, Hainer JW, Sugg J, Munzer D, ATTACH Study Group. Am J Hypertens; 2006 Dec 14; 19(12):1217-25. PubMed ID: 17161766 [Abstract] [Full Text] [Related]
35. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings]. Klaus D. Z Kardiol; 1985 Dec 14; 74 Suppl 7():153-69. PubMed ID: 2936016 [Abstract] [Full Text] [Related]
36. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study. Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Donner K, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Kontula K, Hiltunen TP. J Hypertens; 2008 Jun 14; 26(6):1250-6. PubMed ID: 18475165 [Abstract] [Full Text] [Related]
37. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin. Niutta E, Cusi D, Colombo R, Pellizzoni M, Cesana B, Barlassina C, Soldati L, Bianchi G. J Hypertens Suppl; 1990 Sep 14; 8(4):S53-8. PubMed ID: 2175354 [Abstract] [Full Text] [Related]
38. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives. Fruncillo RJ, Rotmensch HH, Vlasses PH, Koplin JR, Swanson BN, Ferguson RK. Eur J Clin Pharmacol; 1985 Sep 14; 28(1):5-9. PubMed ID: 3886401 [Abstract] [Full Text] [Related]
39. Treatment of hypertension with hydrochlorothiazide and spironolactone. Ogilvie RI, Ruedy J. Can Med Assoc J; 1969 Nov 15; 101(10):61-4. PubMed ID: 5348877 [Abstract] [Full Text] [Related]
40. Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytes. Costa FV, Borghi C, Boschi S, Ambrosioni E. J Cardiovasc Pharmacol; 1985 Nov 15; 7 Suppl 1():S70-6. PubMed ID: 2580180 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]